SCHEMBL3457425

SCHEMBL3457425

Cc1cc(Cl)c(C(=O)NCc2ncc(C(F)(F)F)cc2Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.49
CYP3A4 P08684 3/20 0.49
CYP2C19 P33261 3/20 0.49
CYP2D6 P10635 2/20 0.49
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
NPSR1 Q6W5P4 2/20 0.48
MAPT P10636 2/20 0.47
GLA P06280 1/20 0.47
MAPK1 P28482 1/20 0.46
GAA P10253 1/20 0.46
CYP2C9 P11712 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 2/20 0.45
AGBL2 Q5U5Z8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29356683 0.86 KMT2A (0.61) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL21950 0.86 KMT2A (0.61) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL15286566 0.86 KMT2A (0.61) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL6030344 0.86 CYP1A2 (0.48) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL23367940 0.84 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL3457151 0.83 P2RX7 (0.41) MEN1KMT2AMAPTMAPK1RAB9A
SCHEMBL3456580 0.83 MEN1 (0.47) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL3666907 0.82 KMT2A (0.52) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL23367956 0.81 TP53 (0.51) CYP1A2CYP3A4CYP2C19CYP2D6MEN1
SCHEMBL6031065 0.81 KMT2A (0.51) CYP1A2CYP3A4CYP2C19CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1484970-B1 BENZAMIDES AND COMPOSITIONS COMPRISING BENZAMIDES FOR USE AS FUNGICIDES DU PONT (US) 2013-06-26 EP claimed
EP-2260704-B1 Fungicidal compositions comprising a benzamide and cymoxanil DU PONT (US) 2013-10-16 EP disclosed
EP-1484970-B1 BENZAMIDES AND COMPOSITIONS COMPRISING BENZAMIDES FOR USE AS FUNGICIDES DU PONT (US) 2013-06-26 EP disclosed
EP-2260705-A2 Fungicidal compositions comprising a benzamide and a michondrial respiration inhibitor E. I. du Pont de Nemours and Company (US) 2010-12-15 EP disclosed
EP-2260703-A2 Fungicidal compositions comprising a benzamide and fosetyl-aluminium E. I. du Pont de Nemours and Company (US) 2010-12-15 EP disclosed
EP-2260704-A2 Fungicidal compositions comprising a benzamide and cymoxanil E. I. du Pont de Nemours and Company (US) 2010-12-15 EP disclosed
EP-2258190-A2 Fungicidal compositions comprising a benzamide and a phthalimide E. I. du Pont de Nemours and Company (US) 2010-12-08 EP disclosed
US-20050164999-A1 Benzamides and compositions benzamides for use as fungicizide E. I. DU PONT DE NEMOURS AND COMPANY 2005-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164999-A1 Benzamides and compositions benzamides for use as fungicizide CYC1, ME3, ME2 CYP1A2 106/4885CYP3A4 178/4885CYP2C19 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.